1. CDRH

    Center for devices and radiological health.
  2. DDMAC warning letters and notice of violation letters to pharmaceutical companies

    an informative website
  3. DDMAC Watch/WLF FDA

    WLF carefully monitors (and responds to) every letter sent by Food and Drug Administration (FDA) officials that purports to challenge the pharmaceutical industry's advertising practices.
  4. Drugs@FDA

    complete information on all approved NDAs including approval date(s), review classification, therapeutic equivalents, label and consumer information and history of reviews, letters and warnings. OCP Office of Combination Products (e.g. metered dose inhalers).
  5. FDA Advisory Committees

    committee members, FDA contacts, meeting transcripts, agendas, and more.
  6. Guidance Documents

    dated and arranged by subject with new documents segregated for three months.
  7. OCP

    Office of Combination Products (e.g. metered dose inhalers).
  8. RPM Report

    Health Care Business Intelligence from Windhover Information, includes extensive links for government agencies.
  9. Therapeutic Biological Products

    list of biologicals under the oversight of the Center for Biologics Evaluation and Research (CBER) and those transferred to the Center for Drug Evaluation and Research (CDER).